No takes yet. Share an insight, caveat, or question.
Metabolomics reveals key biomarkers distinguishing systemic sclerosis and lupus, suggesting diverse metabolic pathways.
Singh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: